BioCentury
ARTICLE | Company News

Stryker receives OP-1 HDE

October 18, 2001 7:00 AM UTC

Curis (CRIS) said partner Stryker ( SYK) received humanitarian device exemption (HDE) status from the FDA for CRIS's osteogenic protein-I (OP-1) for use as an alternative to autograft in recalcitrant ...